Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 46 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 23 | 1,138−4.2%/yr | −4.2%/yr | 2.50.8× | 7% | 1,050 in 2030−1.3%/yr |
| Lumbar fusion | 25 | 1,087+7%/yr | +7%/yr | 2.40.9× | 0% | 1,670 in 2030+7.4%/yr |
| Cervical fusion & disc arthroplasty | 9 | 408+2.6%/yr | +2.6%/yr | 0.90.6× | 3% | 500 in 2030+3.4%/yr |
| Kyphoplasty & vertebroplasty | 2 | 213−11%/yr | −11%/yr | 0.50.3× | 0% | 130 in 2030−7.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 141 | 31,628−0.9%/yr | −0.9%/yr | 68.80.9× | 26% | 33,100 in 2030+0.8%/yr |
| Skin substitutes & wound grafts | 5 | 3,495−1.6%/yr | −1.6%/yr | 5.70.7× | 40% | 2,680 in 2030−4.3%/yr |
| Bone graft & orthobiologics | 8 | 349+3.2%/yr | +3.2%/yr | 0.81.2× | 0% | 470 in 2030+5.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 36 | 2,386+2.2%/yr | +2.2%/yr | 5.20.6× | 62% | 2,800 in 2030+2.7%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 3 | 187+13%/yr | +13%/yr | 0.40.4× | 34% | 470 in 2030+17%/yr |
| Spinal cord & DRG stimulation | 3 | 125−16%/yr | −16%/yr | 0.30.4× | 65% | 110 in 2030−1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 8 | 1,121−12%/yr | −12%/yr | 2.40.6× | 11% | 1,490 in 2030+4.9%/yr |
| Superficial venous ablation | 16 | 1,064−7.3%/yr | −7.3%/yr | 2.30.7× | 98% | 970 in 2030−1.5%/yr |
| Dialysis access | 15 | 691−12%/yr | −12%/yr | 1.60.3× | 11% | 760 in 2030+1.5%/yr |
| Carotid revascularization | 11 | 376−4.9%/yr | −4.9%/yr | 0.80.7× | 0% | 380 in 2030+0.3%/yr |
| Thrombectomy, IVC filters & venous stents | 1 | 3090%/yr | 0%/yr | 0.70.5× | 0% | 490 in 2030+8.2%/yr |
| Aortic endografts (EVAR/TEVAR) | 1 | 169+0.7%/yr | +0.7%/yr | 0.40.8× | 0% | 210 in 2030+3.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 22 | 1,777−4.7%/yr | −4.7%/yr | 4.20.7× | 7% | 1,970 in 2030+1.7%/yr |
| Cholecystectomy & appendectomy | 36 | 1,637−4.5%/yr | −4.5%/yr | 3.80.8× | 4% | 1,650 in 2030+0.2%/yr |
| Colorectal resection | 3 | 615−5.1%/yr | −5.1%/yr | 1.40.8× | 0% | 570 in 2030−1.3%/yr |
| Antireflux & hiatal hernia surgery | 3 | 193−6.6%/yr | −6.6%/yr | 0.40.5× | 0% | 300 in 2030+7.6%/yr |
| Breast reconstruction | 0 | 141−3.2%/yr | −3.2%/yr | 0.30.8× | 0% | 120 in 2030−3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 47 | 1,750−0.8%/yr | −0.8%/yr | 4.00.7× | 26% | 1,840 in 2030+0.9%/yr |
| BPH procedures | 29 | 1,578−7.8%/yr | −7.8%/yr | 3.50.8× | 34% | 1,380 in 2030−2.2%/yr |
| Hysterectomy, hysteroscopy & ablation | 12 | 908−1.5%/yr | −1.5%/yr | 2.20.7× | 11% | 880 in 2030−0.4%/yr |
| Incontinence, prolapse & sacral neuromodulation | 7 | 604−0.6%/yr | −0.6%/yr | 1.40.6× | 14% | 600 in 2030−0.1%/yr |
| Prostatectomy & nephrectomy | 8 | 457+1.6%/yr | +1.6%/yr | 1.10.8× | 0% | 470 in 2030+0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 11 | 1,050−4.1%/yr | −4.1%/yr | 2.40.7× | 89% | 1,110 in 2030+1%/yr |
| Sleep apnea & airway implants | 6 | 171+55%/yr | +55%/yr | 0.41.9× | 36% | 140 in 2030−3.5%/yr |
| Ear tubes & middle ear surgery | 1 | 146−9.8%/yr | −9.8%/yr | 0.31.0× | 47% | 110 in 2030−5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 33 | 2,153−2.2%/yr | −2.2%/yr | 5.10.7× | 38% | 2,780 in 2030+4.4%/yr |
| Tumor & fibroid embolization | 3 | 178+14%/yr | +14%/yr | 0.40.8× | 0% | 260 in 2030+6.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 54 | 9,706+30%/yr | +30%/yr | 21.60.8× | 65% | 17,100 in 2030+9.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 34 | 1,666−1.9%/yr | −1.9%/yr | 3.90.7× | 0% | 1,710 in 2030+0.5%/yr |
| EP ablation | 27 | 1,505+14%/yr | +14%/yr | 3.00.9× | 0% | 2,760 in 2030+11%/yr |
| LAA occlusion & loop recorders | 21 | 859+11%/yr | +11%/yr | 1.80.6× | 5% | 1,760 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 58 | 2,810−5.2%/yr | −5.2%/yr | 5.50.9× | 3% | 2,590 in 2030−1.4%/yr |
| Structural heart (TAVR, TEER) | 30 | 618+2.5%/yr | +2.5%/yr | 1.20.7× | 0% | 640 in 2030+0.7%/yr |
| Mechanical circulatory support | 1 | 200−9.7%/yr | −9.7%/yr | 0.50.7× | 0% | 130 in 2030−7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 5 | 166+11%/yr | +11%/yr | 0.40.9× | 0% | 360 in 2030+14%/yr |
| Stroke thrombectomy | 8 | 149+0.7%/yr | +0.7%/yr | 0.30.8× | 0% | 240 in 2030+8%/yr |
| DBS & VNS | 1 | 123−7.4%/yr | −7.4%/yr | 0.30.8× | 0% | 200 in 2030+8.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 68 | 18,172−5.5%/yr | −5.5%/yr | 40.40.6× | 61% | 20,600 in 2030+2.1%/yr |
| Vitreoretinal surgery | 14 | 772+0.4%/yr | +0.4%/yr | 1.80.7× | 67% | 880 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 161 | 33,135−2.3%/yr | −2.3%/yr | 76.70.7× | 39% | 35,000 in 2030+0.9%/yr |
| Bronchoscopy & lung nodule | 25 | 1,181+6.7%/yr | +6.7%/yr | 2.70.7× | 0% | 2,360 in 2030+12%/yr |
| ERCP & endoscopic ultrasound | 11 | 822−0.4%/yr | −0.4%/yr | 1.90.5× | 1% | 920 in 2030+2%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.